CFNTX Fees and Costs — Green California Tax-Free Income Fund, Investor Shares

Data updated: 2026-07-30

The net expense ratio is 0.81%: a 0.50% management fee plus 0.31% other expenses. There are no sales loads or redemption fees. Portfolio turnover was 40%.

CFNTX Fees and Expenses

Annual operating expenses and sales charges of CFNTX. Prospectus, as of December 31, 2025.

Annual operating expenses
Management fee0.50%
12b-1 fee0.00%
Other expenses0.31%
Gross expense ratio0.81%
Fee waiver—
Net expense ratio0.81%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

CFNTX Costs Over Time

On $10,000 invested in CFNTX, assuming 5% a year before costs, total costs come to $509 over 5 years, cutting the return by 0.85% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.81%)$85$266$462
Lost growth on money paid in costs$0$13$47
Total costs$85$279$509
Value after costs$10,415$11,297$12,254
Impact on return, per year0.85%0.85%0.85%

CFNTX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $18.6M
  • Portfolio turnover (prospectus): 40%
  • Securities lending: none during the year

CFNTX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
WELLS FARGO SECURITIES, LLC$11.6M62.09%
MORGAN STANLEY SMITH BARNEY$4.0M21.23%
BANK OF AMERICA SECURITIES LLC$1.3M7.02%
JPMORGAN CHASE$1.0M5.36%
GOLDMAN SACHS & CO. LLC$800K4.29%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.